August 11, 2022 by
Lucy Gardner Carson
(AUGUST 11, 2022) A $20 million grant from the National Institutes of Health to the New England Clinical and Translational Research Network (NNE-CTR) will allow NNE-CTR members from UVM, MaineHealth Institute for Research, and the University of Southern Maine to address chronic and life-threatening diseases in northern New England, VermontBiz reports.
Gary Stein, Ph.D.
(AUGUST 11, 2022) A $20 million grant from the National Institutes of Health to the New England Clinical and Translational Research Network (NNE-CTR) will allow NNE-CTR members from UVM, MaineHealth Institute for Research, and the University of Southern Maine to address chronic and life-threatening diseases in northern New England, VermontBiz reports.
This new funding will both expand the transformative work of the NNE-CTR and reinforce the network’s capacity to provide essential guidance and support for health and health care as the region emerges from the pandemic; restore the momentum for prevention, early detection, treatment, and survivorship with chronic disease; allow the NNE-CTR to invest in new pilot programs to develop innovative disease treatments, community engagement throughout northern New England, and improved data collection and research navigation capabilities; and ensure that the research reflects northern New England’s race, ethnicity, gender, LGBTQ, and socioeconomic diversity.
“The NNE-CTR has exceeded expectations,” said Gary Stein, Ph.D., NNE-CTR principal investigator and UVM chair of biochemistry. “We are optimistic that this grant will provide the resources necessary to make chronic and life-threatening diseases preventable and curable.”
Read full story
at
VermontBiz